Notably, UBE2O orchestrates EMT in ccRCC by ubiquitinating epithelial markers (e.g., E-cadherin) for proteasomal degradation while concurrently upregulating mesenchymal markers such as N-cadherin and Vimentin. The gene discussed is CDH1; the disease is nonpapillary renal cell carcinoma.